Monday 30th May 2022 |
Text too small? |
TruScreen Group Limited (NZX/ASX: TRU) (‘TruScreen’ or ‘the Company’) advises that it will release its preliminary final results for the year ended 31 March 2022 (Results) on 30 May 2022.
Following a board meeting today to consider the Results and the latest update to projections for the next five years, the Directors have resolved to book a provision for impairment of the remaining carrying value of the non-current assets in the amount of ~$4.6 million.
The Directors believe that the intangible assets component of non-current assets, comprising intellectual property and development costs, have substantial value. However, pursuant to Accounting Standard NZ IAS36 Impairment of Assets, a determination is to be made if an indicator of impairment exists. The disruptions experienced from COVID over the previous two financial years will continue and have been exacerbated in the markets where the Company operates, with increased global uncertainties. These include geopolitical tensions in Ukraine, the impact of China’s zero COVID policy with the Chinese borders remaining closed, prolonged COVID lockdowns in other markets, rising inflation and interest rates and disruption to international supply chains.
The Board is of the opinion that given the level of uncertainty, that a full provision for impairment of the remaining carrying value of non-current assets in the amount of ~$4.6m should be made, until some stability returns to our International markets.
The provision for impairment, will be reviewed, as uncertainties recede at future balance dates, and reversed where applicable.
The provision is non-cash and has no impact on the operations of the Company.
This announcement has been approved for release by the Board.
-ENDS-
No comments yet
December 6th Morning Report
December 5th Morning Report
Kiwi Property launches Green Bond offer
TEM - Transaction in Own Shares
December 2nd Morning Report
MWE - Intention to De-list from the NZX Main Board
KMD Brands announces Release of Climate-Related Disclosure
Rua Bioscience expands product range in New Zealand
SPG - HY25 Interim Results
PaySauce FY25 Half Year Result and Interim Report